Balancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease

C Reiff, M Delday, G Rucklidge, M Reid, G Duncan, S Wohlgemuth, G Hoermannsperger, G Loh, M Blaut, E Collie-Duguid, D Haller, D Kelly

Research output: Contribution to journalArticlepeer-review

62 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Balancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences